[1] Its important to note that these uses are not FDA-approved
How GLP-1s Affect Metabolism and Weight GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) mimic a natural gut hormone
Nerve and Brain Injury Studies : Experimental data examine potential neuroprotective roles, which relate to recovery from nerve damage in controlled research environments

Contact your GP or diabetes specialist nurse if you experience: Persistent nausea or vomiting lasting more than a few days, particularly if it prevents you from taking medications or maintaining hydration Inability to eat or drink adequately due to early satiety or abdominal discomfort Rapid or unexplained weight loss exceeding expected therapeutic effects Abdominal pain or distension Vomiting of food consumed several hours previously Worsening blood glucose control despite medication adherence Seek urgent medical attention (contact NHS 111 or attend A&E) if you develop: Severe, persistent vomiting with inability to keep down fluids Signs of dehydration (dark urine, dizziness, confusion, reduced urine output) Severe abdominal pain, especially if radiating to the back and accompanied by vomiting (which could indicate pancreatitis) Vomiting blood or material that looks like coffee grounds Black, tarry stools Your healthcare provider may adjust your treatment plan by reducing the Ozempic dose, temporarily discontinuing the medication, or switching to an alternative diabetes therapy

This detoxification process is particularly critical for individuals exposed to environmental toxins or those with compromised liver function
Cell 80 (3), 485500 e487